References
- Atallah, E.; Flaherty, L. Curr. Treat. Options Oncol. 2005, 6, 185 https://doi.org/10.1007/s11864-005-0002-5
- Barth, A.; Wanek, L. A.; Morton, D. L. J. Am. Coll. Surg. 1995, 181, 193
- Anderson, C. M.; Buzaid, A. C.; Legha, S. S. Oncol. (Williston Park) 1995, 9, 1149
- Gray-Schopfer, V.; Wellbrock, C.; Marais, R. Nature 2007, 445, 851 https://doi.org/10.1038/nature05661
- Garbe, C.; Eigentler, T. K. Melanoma Res. 2007, 17, 117 https://doi.org/10.1097/CMR.0b013e328042bb36
- Koon, H. B.; Atkins, M. B. Expert Rev. Anticancer Ther. 2007, 7, 79 https://doi.org/10.1586/14737140.7.1.79
- Wilhelm, S. M.; Carter, C.; Tang, L.; Wilkie, D.; Mcnabola, A.; Rong, H. Cancer Res. 2004, 64, 7099 https://doi.org/10.1158/0008-5472.CAN-04-1443
- Strumberg, D.; Richly, H.; Hilger, R. A.; Schleucher, N.; Korfee, S. J. Clin. Oncol. 2005, 23, 965 https://doi.org/10.1200/JCO.2005.06.124
- Clark, J. W.; Eder, J. P.; Ryan, D.; Lathia, C.; Lenz, H. J. Clin. Cancer Res. 2005, 11, 5472 https://doi.org/10.1158/1078-0432.CCR-04-2658
- Hirte, H. W.; Moore, M.; Siu, L.; Oza, A.; Hotte, S. J. Ann. Oncol. 2005, 16(10), 1688 https://doi.org/10.1093/annonc/mdi310
- Strumberg, D.; Voliotis, D.; Moller, J. G.; Hilger, R. A.; Richly, H.; Kredtke, S. J. Clin. Pharmacol. Ther. 2002, 40, 580 https://doi.org/10.5414/CPP40580
- Richly, H.; Kupsh, P.; Passage, K.; Grubert, M.; Voigtmann, R.; Schwartz, B. Int. J. Clin. Pharmacol. Ther. 2004, 42, 650 https://doi.org/10.5414/CPP42650
- Smith, R. A.; Barbosa, J.; Blum, C. L.; Bobko, M. A.; Caringal, Y. V.; Dally, R. Bioorg. Med. Chem. Lett. 2001, 11, 2775 https://doi.org/10.1016/S0960-894X(01)00571-6
- Wood, J. E.; Wild, H.; Rogers, D. H.; Lyons, J.; Katz, M. E.; Caringal, Y. V. PCT Pat. APPl. WO 98052559, May 23, 1997
- Bankston, D.; Dumas, J.; Natero, R.; Riedl, D. R.; Monahan, M.- K. Org. Proc. Res. Dev. 2002, 6, 777 https://doi.org/10.1021/op020205n
- Khire, U. R.; Bankston, D.; Barbosa, J.; Brittelli, D. R.; Caringal, Y.; Carlson, R. Bioorg. Med. Chem. Lett. 2004, 14, 783 https://doi.org/10.1016/j.bmcl.2003.11.041
- Wan, P. T. C.; Garnett, M. J.; Roe, S. M.; Lee, S.; Niculescudunaz, D. Cell 2004, 116, 855 https://doi.org/10.1016/S0092-8674(04)00215-6
- Matthew, M. B.; Feng, X.; Marjorie, W.; Robert, A. R.; Edward, J. I. G. J. Org. Chem. 2004, 69, 6257 https://doi.org/10.1021/jo0491096
- Gray-Schopfer, V.; Wellbrock, C.; Marais, R. Nature 2007, 445, 851 https://doi.org/10.1038/nature05661
- Eisen, T.; Ahmad, T.; Flaherty, K. T.; Gore, M.; Kaye, S.; Marais, R.; Gibbens, I.; Hackett, S.; James, M.; Schuchter, L. M.; Nathanson, K. L.; Xia, C.; Simantov, R.; Schwartz, B.; Poulin-Costello, M.; O'Dwyer, P. J.; Ratain, M. J. Br. J. Cancer 2006, 95, 581 https://doi.org/10.1038/sj.bjc.6603291
Cited by
- Synthesis and Preliminary Cytotoxicity Evaluation of New Diarylamides and Diarylureas Possessing 2,3-Dihydropyrrolo[3,2-b]quinoline Scaffold vol.34, pp.8, 2013, https://doi.org/10.5012/bkcs.2013.34.8.2480
- ChemInform Abstract: Synthesis and Antiproliferative Activities of Pyrrolo[2,3-d]pyrimidine Derivatives for Melanoma Cell. vol.40, pp.11, 2009, https://doi.org/10.1002/chin.200911167
- Design, synthesis, and antiproliferative activity of new 1H-pyrrolo[3,2-c]pyridine derivatives against melanoma cell lines vol.46, pp.8, 2008, https://doi.org/10.1016/j.ejmech.2011.04.031
- New diarylureas and diarylamides containing 1,3,4-triarylpyrazole scaffold: Synthesis, antiproliferative evaluation against melanoma cell lines, ERK kinase inhibition, and molecular docking stud vol.46, pp.12, 2008, https://doi.org/10.1016/j.ejmech.2011.08.013
- Design, Synthesis, and Preliminary Cytotoxicity Evaluation of New Diarylureas and Diarylamides Possessing 1,3,4-Triarylpyrazole Scaffold vol.33, pp.9, 2012, https://doi.org/10.5012/bkcs.2012.33.9.2991
- Synthetic Entries to and Biological Activity of Pyrrolopyrimidines vol.116, pp.1, 2016, https://doi.org/10.1021/acs.chemrev.5b00483